Agilent Technologies Inkomsten in het verleden

Verleden criteriumcontroles 6/6

Agilent Technologies is de winst gegroeid met een gemiddeld jaarlijks percentage van 10.6%, terwijl de Life Sciences industrie de winst jaarlijks groeide met 11.7%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 6.7% per jaar. Het rendement op eigen vermogen van Agilent Technologies is 23.9%, en het heeft een nettomarge van 21.7%.

Belangrijke informatie

10.6%

Groei van de winst

12.1%

Groei van de winst per aandeel

Life Sciences Groei van de industrie	21.5%
Inkomstengroei	6.7%
Rendement op eigen vermogen	23.9%
Nettomarge	21.7%
Volgende winstupdate	25 Nov 2024

Recente prestatie-updates uit het verleden

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09

Recent updates

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Oct 21

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Apr 05

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Dec 07

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Oct 26

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Sep 26

Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Sep 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Aug 21

Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Jul 23

Agilent Technologies - A Wealth Compounder 30% Below Its Highs

Jul 13

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Jul 10

What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

May 28

Agilent Technologies Stock: Starting To Look Appealing

May 25

Opbrengsten en kosten

Hoe Agilent Technologies geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NYSE:A Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
31 Jul 24	6,497	1,413	1,764	456
30 Apr 24	6,591	1,242	1,518	465
31 Jan 24	6,735	1,236	1,553	478
31 Oct 23	6,833	1,240	1,578	481
31 Jul 23	6,994	1,133	1,281	486
30 Apr 23	7,040	1,351	1,579	484
31 Jan 23	6,930	1,323	1,585	473
31 Oct 22	6,848	1,254	1,578	467
31 Jul 22	6,659	1,328	1,552	464
30 Apr 22	6,527	1,263	1,548	461
31 Jan 22	6,445	1,205	1,571	455
31 Oct 21	6,319	1,210	1,562	441
31 Jul 21	6,142	990	1,562	426
30 Apr 21	5,817	925	1,464	405
31 Jan 21	5,530	810	1,404	396
31 Oct 20	5,339	719	1,395	397
31 Jul 20	5,223	691	1,377	398
30 Apr 20	5,236	683	1,446	407
31 Jan 20	5,236	764	1,405	406
31 Oct 19	5,163	1,071	1,358	404
31 Jul 19	5,090	1,072	1,343	406
30 Apr 19	5,019	1,117	1,290	402
31 Jan 19	4,987	1,140	1,301	395
31 Oct 18	4,914	316	1,322	387
31 Jul 18	4,809	298	1,284	372
30 Apr 18	4,720	237	1,269	362
31 Jan 18	4,616	196	1,235	354
31 Oct 17	4,472	684	1,205	341
31 Jul 17	4,394	633	1,173	330
30 Apr 17	4,324	582	1,167	329
31 Jan 17	4,241	509	1,159	326
31 Oct 16	4,202	462	1,174	325
31 Jul 16	4,126	476	1,184	324
30 Apr 16	4,096	465	1,175	317
31 Jan 16	4,040	466	1,170	317
31 Oct 15	4,038	438	1,189	327
31 Jul 15	4,046	306	1,189	340
30 Apr 15	4,041	256	1,184	347
31 Jan 15	4,066	204	1,196	353
31 Oct 14	4,048	232	1,199	358
31 Jul 14	4,723	435	1,325	434
30 Apr 14	5,366	540	1,490	518
31 Jan 14	6,110	666	1,654	604

Kwaliteitswinsten: A heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (21.7%) A } zijn hoger dan vorig jaar (16.2%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van A is de afgelopen 5 jaar met 10.6% per jaar gegroeid.

Versnelling van de groei: De winstgroei van A over het afgelopen jaar ( 24.7% ) overtreft het 5-jarig gemiddelde ( 10.6% per jaar).

Winst versus industrie: De winstgroei A over het afgelopen jaar ( 24.7% ) overtrof de Life Sciences -sector -4.7%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 23.9% ) van A wordt als hoog beschouwd.

Agilent Technologies Inkomsten in het verleden

Verleden criteriumcontroles 6/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024

Second quarter 2024 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Recent updates

Agilent Technologies, Inc. Increases Quarterly Cash Dividend, Payable on January 22, 2025

Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024

Insider notifies of intention to sell stock

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Third quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. Receives FDA Approval for Mage-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent Technologies, Inc. (NYSE:A) acquired Sigsense Technologies, Inc.

Agilent: Making A Move To Ignite Some Growth

Agilent Technologies, Inc. Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit

Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index

Now 20% undervalued after recent price drop

Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary

Insider recently sold US$2.0m worth of stock

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Price target decreased by 7.2% to US$140

Second quarter 2024 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency

First quarter dividend of US$0.24 announced

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024

Agilent Technologies, Inc. Announces New Proteoanalyzer System

Agilent Technologies Hit A Homerun

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Makes Strategic Updates to Organizational Structure

Insider recently sold US$2.0m worth of stock

Insider notifies of intention to sell stock

CEO, President & Director notifies of intention to sell stock

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader

Full year 2023 earnings: EPS exceeds analyst expectations

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

Agilent Technologies: Looking Undervalued Heading Into Earnings

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Now 20% undervalued after recent price drop

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Upcoming dividend of US$0.23 per share at 0.8% yield

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A).